{"id":2442,"date":"2025-01-15T16:01:43","date_gmt":"2025-01-15T13:01:43","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=2442"},"modified":"2025-03-07T14:57:03","modified_gmt":"2025-03-07T11:57:03","slug":"3-drugs-receiving-accelerated-approval-from-the-fda-and-reviewed-by-the-office-of-inspector-general-raised-concerns","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/pt\/3-drugs-receiving-accelerated-approval-from-the-fda-and-reviewed-by-the-office-of-inspector-general-raised-concerns\/","title":{"rendered":"3 medicamentos que receberam aprova\u00e7\u00e3o acelerada do FDA e foram revisados pelo Gabinete do Inspetor Geral levantaram preocupa\u00e7\u00f5es"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Apesar das evid\u00eancias inst\u00e1veis e das diferen\u00e7as entre os revisores, a Food and Drug Administration dos EUA aprovou rapidamente o Aduhelm da Biogen, o Exondys 51 (eteplirsen) da Sarepta e o Makena da Covis Pharma, informou o Escrit\u00f3rio do Inspetor Geral do Departamento de Sa\u00fade e Servi\u00e7os Humanos na ter\u00e7a-feira. A an\u00e1lise descobriu que, em um caso, n\u00e3o havia documenta\u00e7\u00e3o sobre escolhas importantes.<\/p>","protected":false},"excerpt":{"rendered":"<p>Apesar das evid\u00eancias inst\u00e1veis e das diferen\u00e7as entre os revisores, a Food and Drug Administration dos EUA aprovou rapidamente o Aduhelm da Biogen, o Exondys 51 (eteplirsen) da Sarepta e o Makena da Covis Pharma, informou o Escrit\u00f3rio do Inspetor Geral do Departamento de Sa\u00fade e Servi\u00e7os Humanos na ter\u00e7a-feira. A an\u00e1lise descobriu que, em um caso, n\u00e3o havia documenta\u00e7\u00e3o sobre escolhas importantes.<\/p>","protected":false},"author":1,"featured_media":2444,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[119,120,88,162,65],"class_list":["post-2442","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-eteplirsen","tag-exondys-51","tag-fda","tag-office-of-inspector-general","tag-sarepta"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/posts\/2442","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/comments?post=2442"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/posts\/2442\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/media\/2444"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/media?parent=2442"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/categories?post=2442"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/tags?post=2442"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}